Pesquisa | Biblioteca Virtual em Saúde

1.

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial.

Reich, Kristian; Gooderham, Melinda; Thaçi, Diamant; Crowley, Jeffrey J; Ryan, Caitriona; Krueger, James G; Tsai, Tsen-Fang; Flack, Mary; Gu, Yihua; Williams, David A; Thompson, Elizabeth H Z; Paul, Carle.

Lancet; 394(10198): 576-586, 2019 08 17.

Artigo em Inglês | MEDLINE | ID: mdl-31280967

2.

Predictors of time to relapse following ustekinumab withdrawal in patients with psoriasis who had responded to therapy: An eight-year multicenter study.

Chiu, Hsien-Yi; Hui, Rosaline Chung-Yee; Tsai, Tsen-Fang; Chen, Yang-Ching; Chang Liao, Nien-Feng; Chen, Po-Hua; Lai, Po-Ju; Wang, Ting-Shun; Huang, Yu-Huei.

J Am Acad Dermatol; 2019 Jan 28.

Artigo em Inglês | MEDLINE | ID: mdl-30703455

3.

Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2.

Genovese, Mark C; Combe, Benard; Kremer, Joel M; Tsai, Tsen-Fang; Behrens, Frank; Adams, David H; Lee, Chin; Kerr, Lisa; Nash, Peter.

Rheumatology (Oxford); 57(11): 2001-2011, 2018 Nov 01.

Artigo em Inglês | MEDLINE | ID: mdl-30053162

4.

Safety Proï¬le of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study.

Chiu, Hsien-Yi; Hui, Rosaline Chung-Yee; Huang, Yu-Huei; Huang, Ruey-Yun; Chen, Kai-Lung; Tsai, Ya-Chu; Lai, Po-Ju; Wang, Ting-Shun; Tsai, Tsen-Fang.

Acta Derm Venereol; 98(9): 829-834, 2018 Oct 10.

Artigo em Inglês | MEDLINE | ID: mdl-29972221

5.

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis.

Bachelez, Hervé; Choon, Siew-Eng; Marrakchi, Slaheddine; Burden, A David; Tsai, Tsen-Fang; Morita, Akimichi; Turki, Hamida; Hall, David B; Shear, Michael; Baum, Patrick; Padula, Steven J; Thoma, Christian.

N Engl J Med; 380(10): 981-983, 2019 03 07.

Artigo em Inglês | MEDLINE | ID: mdl-30855749

6.

Secukinumab in plaque psoriasis--results of two phase 3 trials.

Langley, Richard G; Elewski, Boni E; Lebwohl, Mark; Reich, Kristian; Griffiths, Christopher E M; Papp, Kim; Puig, Lluís; Nakagawa, Hidemi; Spelman, Lynda; Sigurgeirsson, Bárður; Rivas, Enrique; Tsai, Tsen-Fang; Wasel, Norman; Tyring, Stephen; Salko, Thomas; Hampele, Isabelle; Notter, Marianne; Karpov, Alexander; Helou, Silvia; Papavassilis, Charis.

N Engl J Med; 371(4): 326-38, 2014 Jul 24.

Artigo em Inglês | MEDLINE | ID: mdl-25007392

7.

Increased risk of avascular necrosis in patients with psoriatic disease: A nationwide population-based matched cohort study.

Chiu, Hsien-Yi; Wang, I-Ting; Huang, Weng-Foung; Tsai, Yi-Wen; Shiu, Ming-Neng; Tsai, Tsen-Fang.

J Am Acad Dermatol; 76(5): 903-910.e1, 2017 May.

Artigo em Inglês | MEDLINE | ID: mdl-27986394

8.

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.

Blauvelt, Andrew; Reich, Kristian; Tsai, Tsen-Fang; Tyring, Stephen; Vanaclocha, Francisco; Kingo, Külli; Ziv, Michael; Pinter, Andreas; Vender, Ronald; Hugot, Sophie; You, Ruquan; Milutinovic, Marina; Thaçi, Diamant.

J Am Acad Dermatol; 76(1): 60-69.e9, 2017 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-27663079

9.

Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.

Rampakakis, Emmanouil; Stutz, Melissa; Kawai, Kosuke; Tsai, Tsen-Fang; Cheong, Hee Jin; Dhitavat, Jittima; Ortiz-Covarrubias, Alejandro; Cashat-Cruz, Miguel; Monsanto, Homero; Johnson, Kelly D; Sampalis, John S; Acosta, Camilo J.

Health Qual Life Outcomes; 15(1): 11, 2017 Jan 18.

Artigo em Inglês | MEDLINE | ID: mdl-28100258

10.

Increased risk of aortic aneurysm (AA) in relation to the severity of psoriasis: A national population-based matched-cohort study.

Chiu, Hsien-Yi; Lo, Po-Ching; Huang, Weng-Foung; Tsai, Yi-Wen; Tsai, Tsen-Fang.

J Am Acad Dermatol; 75(4): 747-754, 2016 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-27473449

11.

Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis.

van de Kerkhof, Peter C M; Griffiths, Christopher E M; Reich, Kristian; Leonardi, Craig L; Blauvelt, Andrew; Tsai, Tsen-Fang; Gong, Yankun; Huang, Jiaqing; Papavassilis, Charis; Fox, Todd.

J Am Acad Dermatol; 75(1): 83-98.e4, 2016 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-27180926

12.

Efficacy and Safety of IncobotulinumtoxinA in Asian Subjects: A Pooled Analysis of Clinical Trials in the Treatment of Glabellar Frown Lines.

Seo, Kyle; Tsai, Tsen-Fang; Chao, Yates Yen-Yu; Goodman, Greg J.

J Drugs Dermatol; 15(9): 1084-7, 2016 Sep 01.

Artigo em Inglês | MEDLINE | ID: mdl-27602970

13.

Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials.

Menter, M Alan; Papp, Kim A; Cather, Jennifer; Leonardi, Craig; Pariser, David M; Krueger, James G; Wohlrab, Johannes; Amaya-Guerra, Mario; Kaszuba, Andrzej; Nadashkevich, Oleg; Tsai, Tsen-Fang; Gupta, Pankaj; Tan, Huaming; Valdez, Hernan; Mallbris, Lotus; Tatulych, Svitlana.

J Drugs Dermatol; 15(5): 568-80, 2016 May 01.

Artigo em Inglês | MEDLINE | ID: mdl-27168266

14.

Taiwanese Dermatological Association consensus for the definition, classification, diagnosis, and management of urticaria.

Chung, Wen-Hung; Chu, Chia-Yu; Huang, Yu-Huei; Wang, Wei-Ming; Yang, Chih-Hsun; Tsai, Tsen-Fang.

J Formos Med Assoc; 115(11): 968-980, 2016 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-26679383

15.

Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study.

Chiu, Hsien-Yi; Chang, Wei-Lun; Huang, Weng-Foung; Wen, Yu-Wen; Tsai, Yi-Wen; Tsai, Tsen-Fang.

J Am Acad Dermatol; 73(3): 429-38, 2015 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-26188627

16.

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.

Thaçi, Diamant; Blauvelt, Andrew; Reich, Kristian; Tsai, Tsen-Fang; Vanaclocha, Francisco; Kingo, Külli; Ziv, Michael; Pinter, Andreas; Hugot, Sophie; You, Ruquan; Milutinovic, Marina.

J Am Acad Dermatol; 73(3): 400-9, 2015 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-26092291

17.

Risk Factor Analysis for the Immunogenicity of Adalimumab Associated with Decreased Clinical Response in Chinese Patients with Psoriasis.

Chiu, Hsien-Yi; Wang, Ting-Shun; Chan, Chih-Chieh; Lin, Sung-Jan; Tsai, Tsen-Fang.

Acta Derm Venereol; 95(6): 711-6, 2015 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-25673333

18.

A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.

Gubelin Harcha, Walter; Barboza Martínez, Julia; Tsai, Tsen-Fang; Katsuoka, Kensei; Kawashima, Makoto; Tsuboi, Ryoji; Barnes, Allison; Ferron-Brady, Geraldine; Chetty, Dushen.

J Am Acad Dermatol; 70(3): 489-498.e3, 2014 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-24411083

19.

Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study.

Thaçi, Diamant; Puig, Lluís; Reich, Kristian; Tsai, Tsen-Fang; Tyring, Stephen; Kingo, Külli; Ziv, Michael; Pinter, Andreas; Vender, Ronald; Lacombe, Aude; Xia, Summer; Bhosekar, Vaishali; Gilloteau, Isabelle; Guana, Adriana; Blauvelt, Andrew.

J Am Acad Dermatol; 81(6): 1405-1409, 2019 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-31399223

20.

Cutaneous irritancy of water.

Wang, Ting-Shun; Tsai, Tsen-Fang.

Rev Environ Health; 29(3): 217-20, 2014.

Artigo em Inglês | MEDLINE | ID: mdl-25274940

Biblioteca Virtual em Saúde

Brasil

Sua seleção (0)

Formato de exportação:

Exportar: